Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Andes

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
Plos Biology|May 5, 2005
Inhibition of mutation and combating the evolution of antibiotic resistanceRyan T Cirz, Jodie K Chin, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
<i>In Vivo</i> Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse ModelMiao Zhao, Alexander J Lepak, Brian VanScoy, et al.
Molecular Microbiology|July 31, 2013
The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosisLeona A Connolly, Alessandro Riccombeni, Zsuzsana Grózer, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Novel keto-alkyl-pyridinium antifungal molecules active in models of in vivo <i>Candida albicans</i> vascular catheter infection and ex vivo <i>Candida auris</i> skin colonizationSarah R Beattie, Taiwo Esan, Robert Zarnowski, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Genetic interaction analysis of <i>Candida glabrata</i> transcription factors <i>CST6</i> and <i>UPC2A</i> in the regulation of respiration and fluconazole susceptibilityTomye L Ollinger, Robert Zarnowski, Josie E Parker, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2023
Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of <i>In Vivo</i> Candida albicans Vascular Catheter Infection and <i>Ex Vivo</i> Candida auris Skin ColonizationSarah R Beattie, Taiwo Esan, Robert Zarnowski, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Impact of Triazole Therapeutic Drug Monitoring Availability and TimingErin K McCreary, Meg Bayless, Ahn P Van, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniaeAlexander J Lepak, Miao Zhao, Qingmei Liu, et al.
The Journal of Biological Chemistry|December 30, 2018
Exploiting the vulnerable active site of a copper-only superoxide dismutase to disrupt fungal pathogenesisNatalie G Robinett, Edward M Culbertson, Ryan L Peterson, et al.
Open Forum Infectious Diseases|July 16, 2020
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming PatientsPaul G Ambrose, Sujata M Bhavnani, David R Andes, et al.
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
Plos Biology|May 5, 2005
Inhibition of mutation and combating the evolution of antibiotic resistanceRyan T Cirz, Jodie K Chin, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2018
<i>In Vivo</i> Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse ModelMiao Zhao, Alexander J Lepak, Brian VanScoy, et al.
Molecular Microbiology|July 31, 2013
The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosisLeona A Connolly, Alessandro Riccombeni, Zsuzsana Grózer, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Novel keto-alkyl-pyridinium antifungal molecules active in models of in vivo <i>Candida albicans</i> vascular catheter infection and ex vivo <i>Candida auris</i> skin colonizationSarah R Beattie, Taiwo Esan, Robert Zarnowski, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Genetic interaction analysis of <i>Candida glabrata</i> transcription factors <i>CST6</i> and <i>UPC2A</i> in the regulation of respiration and fluconazole susceptibilityTomye L Ollinger, Robert Zarnowski, Josie E Parker, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2023
Novel Keto-Alkyl-Pyridinium Antifungal Molecules Active in Models of <i>In Vivo</i> Candida albicans Vascular Catheter Infection and <i>Ex Vivo</i> Candida auris Skin ColonizationSarah R Beattie, Taiwo Esan, Robert Zarnowski, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Impact of Triazole Therapeutic Drug Monitoring Availability and TimingErin K McCreary, Meg Bayless, Ahn P Van, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniaeAlexander J Lepak, Miao Zhao, Qingmei Liu, et al.
The Journal of Biological Chemistry|December 30, 2018
Exploiting the vulnerable active site of a copper-only superoxide dismutase to disrupt fungal pathogenesisNatalie G Robinett, Edward M Culbertson, Ryan L Peterson, et al.
Open Forum Infectious Diseases|July 16, 2020
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming PatientsPaul G Ambrose, Sujata M Bhavnani, David R Andes, et al.
Pageof 21